http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0411165-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fc35782f9b1bd8e4a688773dfcfdf14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K-
filingDate 2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed3079c51aa742ff1e655ada86295bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c540432dce4b3c2a3572c59aac87fa6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49fc621dcbc931982d68b38c6f69c09e
publicationDate 2006-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0411165-A
titleOfInvention pharmaceutical composition, dosage unit form and methods for preparing its use
abstract "PHARMACEUTICAL COMPOSITION, DOSAGE UNIT FORM AND METHODS TO PREPARE YOUR USE". The present invention provides a composition (e.g., a pharmaceutical composition) comprising at least one release agent compound and at least one YY peptide (PYY) and a PYY agonist. Preferably, the composition includes a therapeutically effective amount of peptide YY or PYY agonist and release agent compound. The composition of the present invention facilitates the release of PYY, a PYY agonist, or a mixture thereof and increases their bioavailability compared to administration without the release agent compound. PYY and PYY agonists have activity as agents to reduce nutrient availability, including reducing food intake.
priorityDate 2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423545195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30211
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395564
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68005
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10082
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51694
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6X3U9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68004
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID615800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9I8P2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TR93
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5697
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID217212
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ76CL2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9EPS2

Total number of triples: 40.